Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Awatif Hafiz PharmD, BCCP"'
Autor:
Awatif Hafiz PharmD, BCCP, Hadeel Alkofide PhD, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Hala Joharji PharmD, BCPS, BCMTM, Sarah Aljohani PharmD, BCPS, Khadijah A. Sarkhi PharmD, Reem Alharbi PharmD, Ghazwa B. Korayem PharmD, BCPS, Mashael AlFaifi PharmD, BCPS, Samiah Alsohimi PharmD, Ohoud Aljuhani PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
The prevalence of venous thromboembolism is high in patients with COVID-19, despite prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis regimen in non-critically ill patients with mild to moderate COVID-19 is sti
Externí odkaz:
https://doaj.org/article/ef4a26e56ccb4240bf800fe922df2a42
Autor:
Khalid Al Sulaiman SCC-CCP, BCCCP, BCNSP, MBA, Awatif Hafiz PharmD, BCCP, Hisham A. Badreldin PharmD, FCCP, BCPS, BCCP, Ghazwa B. Korayem PharmD, BCPS, Faisal Alsuwayyid PharmD, Abdulrahman Alrashidi, PharmD, Mohammed Alhijris PharmD, Faisal Almutairi, PharmD, Fahad Alharthi PharmD, Saad Alghamdi PharmD, Ahmed Abu Alreesh ClinPharmM.Sc, Ohoud Aljuhani PharmD, BCCCP
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022)
Several guidelines endorsed the indefinite use warfarin or heparin-containing products for acute venous thromboembolism (VTE) treatment and secondary prevention and discouraged the use of direct oral anticoagulants (DOAC) for patients diagnosed with
Externí odkaz:
https://doaj.org/article/0cd5b2b17db149f7ba754f25f631240b